Market By Drugs & Devices And Geography | Forecast 2019- 2027
According to Triton Market Research, the market for ophthalmology drugs and devices in Latin America is expected to burgeon with a CAGR of 5.31% in the forecast period 2019-2027.
The countries that have been considered in the Latin America ophthalmology drugs and devices market are:
• Mexico
• Brazil
• Rest of Latin America
Report scope can be customized per your requirements. Request For Customization
The Latin America ophthalmology drugs and devices market is precisely driven owing to the escalating prevalence of diabetes, along with the increasing healthcare expenditure, mainly in the countries of Brazil and Argentina. Brazil is spending a massive amount of capital in the healthcare sector, in purchasing new devices and instruments. According to the International Trade Administration, public and private healthcare expense in Brazil amounts to around 9.6% of the GDP. Out of this sum, about $10.4 billion was accounted to purchase of medical equipment and devices, paving the growth & adoption of the ophthalmological drugs and devices market in the country. Diabetes causes a direct impact on the eyes. Although a large number of non-diabetic people get cataracts, people having diabetes have 60% more chances of developing this eye condition, that too, at a younger age and have it develop at a faster rate. In addition, as per the World Health Organization, the healthcare expenditure in Argentina accounted for about 7% of the GDP in 2015. In 2015, according to the World Economic Forum, 22.5% of the total expenditure by the Argentinian government was towards healthcare, which is further augmenting the growth of the ophthalmology drugs and devices market in the Latin American region.
Novartis International AG is a Switzerland-based multinational pharmaceutical company. The company majorly manufactures products related to generic drugs, pharmaceuticals, OTC drugs, vaccines, diagnostics, animal health products, contact lenses, etc. The company has its global footprint in more than 155 countries, including Argentina, Brazil, Canada, China, Hong Kong, India, Russia, Spain, the UK, the US, Italy, etc. The company had accounted for a total revenue share worth $48.5 billion in 2016.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. LATIN
AMERICA OPHTHALMOLOGY DRUGS AND DEVICES MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. MARKET
DEFINITION
2.2. PORTER’S
FIVE FORCES ANALYSIS
2.2.1. BARGAINING
POWER OF BUYERS
2.2.2. BARGAINING
POWER OF SUPPLIER
2.2.3. THREATS
OF NEW ENTRANTS
2.2.4. THREATS
OF SUBSTITUTES
2.2.5. COMPETITIVE
RIVALRY
2.3. STRATEGIC
OUTLOOK
2.4. KEY
INSIGHT
2.5. VALUE
CHAIN OUTLOOK
2.6. KEY
BUYING STANDARDS
2.7. INVESTMENT
OUTLOOK
2.8. SUPPLY
CHAIN OUTLOOK
2.9. MARKET
DRIVERS
2.9.1. INCREASING
OPHTHALMIC DISORDERS DUE TO HIGH BLOOD SUGAR
2.9.2. UPSURGE
IN HEALTHCARE SPENDING
2.9.3. TECHNOLOGICAL
ADVANCEMENT
2.10.
MARKET RESTRAINTS
2.10.1.
EXPIRATIONS OF BRAND PATENTS
HAVE AFFECTED THE PHARMACEUTICAL INDUSTRY
2.10.2.
LOW COGNIZANCE RELATED TO
OPHTHALMIC DRUGS
2.10.3.
DRUG APPROVALS DELAY AND
NUMBER OF DRUGS IN THE PIPELINE
2.11.
MARKET OPPORTUNITIES
2.11.1.
DEMAND FOR PHACOEMULSIFICATION
DEVICES AND INTRAOCULAR LENSES IS INCREASING
2.12.
MARKET CHALLENGES
2.12.1.
DIFFICULTIES ASSOCIATED WITH
THE CONDUCT OF OCULAR DISEASES
3. OPHTHALMOLOGY
DRUGS AND DEVICES MARKET OUTLOOK - BY DRUGS AND DEVICES
3.1. DEVICES
3.1.1. DIAGNOSTIC
& MONITORING EQUIPMENT
3.1.1.1. OPTICAL
COHERENCE TOMOGRAPHY
3.1.1.2. OPHTHALMIC
ULTRASOUND IMAGING SYSTEMS
3.1.1.3. FUNDUS
CAMERA MARKET
3.1.1.4. OPHTHALMOSCOPES
3.1.1.5. RETINOSCOPE
3.1.1.6. PACHYMETER
3.1.1.7. WAVEFRONT
ABERROMETERS
3.1.1.8. PERIMETERS/VISUAL
FIELD ANALYZER
3.1.1.9. AUTOREFRACTORS/PHOROPTER
3.1.1.10. SPECULAR
MICROSCOPE
3.1.1.11. CORNEAL
TOPOGRAPHERS
3.1.1.12. OTHER
DIAGNOSTIC & MONITORING EQUIPMENT MARKET
3.1.2. SURGERY
DEVICES
3.1.2.1. CATARACT
SURGERY DEVICES
3.1.2.2. GLAUCOMA
SURGERY DEVICES
3.1.2.3. REFRACTIVE
SURGERY DEVICES
3.1.2.4. VITREORETINAL
SURGERY DEVICES
3.2. VISION
CARE
3.3. DRUGS
3.3.1. GLAUCOMA
DRUG
3.3.2. RETINAL
DISORDER DRUG
3.3.3. DRY
EYE DRUG
3.3.4. ALLERGIC
CONJUNCTIVITIS, INFLAMMATION AND CONJUNCTIVITIS DRUG
3.3.5. DRUGS
BY USE OF PRESERVATION
3.3.5.1. PRESERVED
DRUGS
3.3.5.2. PRESERVATIVE
FREE DRUGS
4. OPHTHALMOLOGY
DRUGS AND DEVICES MARKET - REGIONAL OUTLOOK
4.1.1. BRAZIL
4.1.2. MEXICO
4.1.3. REST
OF LATIN AMERICA
5. COMPETITIVE
LANDSCAPE
5.1. ALLERGAN,
INC.
5.2. BAYER
5.3. CARL
ZEISS AG
5.4. ESSILOR
INTERNATIONAL S.A.
5.5. GLAXOSMITHKLINE
5.6. JOHNSON
& JOHNSON, INC.
5.7. NOVARTIS
INTERNATIONAL AG
5.8. PFIZER
5.9. ROCHE
HOLDING AG
5.10.
SANTEN PHARMACEUTICAL CO.,
LTD.
6. METHODOLOGY
AND SCOPE
6.1. RESEARCH
SCOPE
6.2. SOURCES
OF DATA
6.3. RESEARCH
METHODOLOGY
TABLE 1 LATIN AMERICA OPHTHALMOLOGY DRUGS AND
DEVICES MARKET 2019-2027 ($ MILLION)
TABLE 2 COMMON CAUSES OF LOSS OF VISION IN THE
ELDERLY
TABLE 3 SELECTED LISTS OF GLAUCOMA DRUGS IN
LATE-STAGE CLINICAL TRIALS
TABLE 4 LATIN AMERICA OPHTHALMOLOGY DRUGS AND
DEVICES MARKET BY DRUGS AND DEVICES 2019-2027 ($ MILLION)
TABLE 5 LATIN AMERICA DEVICES MARKET IN
DIAGNOSTIC & MONITORING EQUIPMENT BY
TYPES 2019-2027 ($ MILLION)
TABLE 6 LATIN AMERICA DEVICES MARKET IN SURGERY
DEVICE BY TYPES 2019-2027 ($ MILLION)
TABLE 7 LATIN AMERICA DRUGS AND DEVICES MARKET
IN DRUGS BY TYPES 2019-2027 ($ MILLION)
TABLE 8 LATIN AMERICA OPHTHALMOLOGY DRUGS AND
DEVICES MARKET BY COUNTRIES 2019-2027 ($ MILLION)
FIGURE 1 LATIN AMERICA
OPHTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027
FIGURE 2 LATIN AMERICA DRUGS
AND DEVICES MARKET IN DEVICES 2019-2027 ($ MILLION)
FIGURE 3 LATIN AMERICA DEVICES
MARKET IN DIAGNOSTIC & MONITORING EQUIPMENT 2019-2027 ($ MILLION)
FIGURE 4 LATIN AMERICA
DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN OPTICAL COHERENCE TOMOGRAPHY
2019-2027 ($ MILLION)
FIGURE 5 LATIN AMERICA
DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN OPHTHALMIC ULTRASOUND IMAGING
SYSTEMS 2019-2027 ($ MILLION)
FIGURE 6 LATIN AMERICA
DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN FUNDUS CAMERA MARKET 2019-2027
($ MILLION)
FIGURE 7 LATIN AMERICA
DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN OPHTHALMOSCOPES 2019-2027 ($
MILLION)
FIGURE 8 LATIN AMERICA
DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN RETINOSCOPE 2019-2027 ($
MILLION)
FIGURE 9 LATIN AMERICA
DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN PACHYMETER 2019-2027 ($
MILLION)
FIGURE 10 LATIN AMERICA DIAGNOSTIC
& MONITORING EQUIPMENT MARKET IN WAVEFRONT ABERROMETERS 2019-2027 ($
MILLION)
FIGURE 11 LATIN AMERICA
DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN PERIMETERS/VISUAL FIELD ANALYZER
2019-2027 ($ MILLION)
FIGURE 12 LATIN AMERICA DIAGNOSTIC
& MONITORING EQUIPMENT MARKET IN AUTOREFRACTORS/PHOROPTER 2019-2027 ($
MILLION)
FIGURE 13 LATIN AMERICA DIAGNOSTIC
& MONITORING EQUIPMENT MARKET IN SPECULAR MICROSCOPE 2019-2027 ($ MILLION)
FIGURE 14 LATIN AMERICA DIAGNOSTIC
& MONITORING EQUIPMENT MARKET IN CORNEAL TOPOGRAPHERS 2019-2027 ($ MILLION)
FIGURE 15 LATIN AMERICA DIAGNOSTIC
& MONITORING EQUIPMENT MARKET IN OTHER DIAGNOSTIC & MONITORING
EQUIPMENT MARKET 2019-2027 ($ MILLION)
FIGURE 16 LATIN AMERICA DEVICES
MARKET IN SURGERY DEVICE 2019-2027 ($ MILLION)
FIGURE 17 LATIN AMERICA SURGERY
DEVICES MARKET IN CATARACT SURGERY DEVICES 2019-2027 ($ MILLION)
FIGURE 18 LATIN AMERICA SURGERY
DEVICES MARKET IN GLAUCOMA SURGERY DEVICES 2019-2027 ($ MILLION)
FIGURE 19 LATIN AMERICA SURGERY
DEVICES MARKET IN REFRACTIVE SURGERY DEVICES 2019-2027 ($ MILLION)
FIGURE 20 LATIN AMERICA SURGERY
DEVICES MARKET IN VITREORETINAL SURGERY DEVICES 2019-2027 ($ MILLION)
FIGURE 21 LATIN AMERICA DEVICES
MARKET IN VISION CARE MARKET 2019-2027 ($ MILLION)
FIGURE 22 LATIN AMERICA DRUGS AND
DEVICES MARKET IN DRUGS 2019-2027 ($ MILLION)
FIGURE 23 LATIN AMERICA DRUGS
MARKET IN GLAUCOMA DRUG 2019-2027 ($ MILLION)
FIGURE 24 LATIN AMERICA DRUGS
MARKET IN RETINAL DISORDER DRUG 2019-2027 ($ MILLION)
FIGURE 25 LATIN AMERICA DRUGS
MARKET IN DRY EYE DRUG 2019-2027 ($ MILLION)
FIGURE 26 LATIN AMERICA DRUGS
MARKET IN ALLERGIC CONJUNCTIVITIS, INFLAMMATION AND CONJUNCTIVITIS DRUG
2019-2027 ($ MILLION)
FIGURE 27 LATIN AMERICA DRUGS BY
USE OF PRESERVATION IN PRESERVED DRUGS 2019-2027 ($ MILLION)
FIGURE 28 LATIN AMERICA DRUGS BY
USE OF PRESERVATION IN PRESERVATION-FREE DRUGS 2019-2027 ($ MILLION)
FIGURE 29 LATIN AMERICA
PRESERVATION-FREE DRUGS MARKET IN SINGLE-DOSE 2019-2027 ($ MILLION)
FIGURE 30 LATIN AMERICA
PRESERVATION-FREE DRUGS MARKET IN MULTI-DOSE 2019-2027 ($ MILLION)
FIGURE 31 LATIN AMERICA
OPHTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 32 BRAZIL COUNTRIES
OPHTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 33 MEXICO COUNTRIES
OPHTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 34 REST OF LATIN AMERICA
COUNTRIES OPHTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)